Worth thinking about what an abundance of caution would really look like, here.https://twitter.com/US_FDA/status/1381925612743499778 …
-
-
Also convening ACIP tomorrow to discuss, so they’re moving quickly and I imagine will clear it. But yeah, the dramatic pause is something that can’t be taken back.
-
Don’t need a cost effectiveness analysis to say that waiting until after the ACIP meeting was probably correct, unless there is already something we don’t know
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.